# Phase Ib Trial of Injectable RAB001 for Knee Osteoarthritis

> **NCT07652372** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** RAB001 medium dose

## Key facts

- **NCT ID:** NCT07652372
- **Lead sponsor:** ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-04-16
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652372, "Phase Ib Trial of Injectable RAB001 for Knee Osteoarthritis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*